PROFUSA Return on Tangible Equity 2022-2021 | PFSA

Current and historical return on tangible equity values for PROFUSA (PFSA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
PROFUSA Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.005B $0.000B
Profusa Inc. is a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry. Profusa Inc., formerly known as NorthView Acquisition Corp., is based in BERKELEY, Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.937B 59.72
Hims & Hers Health (HIMS) United States $13.490B 140.16
Doximity (DOCS) United States $11.213B 51.91
Tempus AI (TEM) United States $10.091B 0.00
IRhythm Technologies (IRTC) United States $4.366B 0.00
Inspire Medical Systems (INSP) United States $3.822B 59.72
Hinge Health (HNGE) United States $3.402B 0.00
Privia Health (PRVA) United States $2.375B 162.33
10x Genomics (TXG) United States $1.724B 0.00
Phreesia (PHR) United States $1.614B 0.00
Enovis (ENOV) United States $1.561B 8.70
Schrodinger (SDGR) United States $1.553B 0.00
Azenta (AZTA) United States $1.553B 72.17
Clover Health Investments (CLOV) United States $1.471B 0.00
Omnicell (OMCL) United States $1.387B 24.48
Evolent Health (EVH) United States $1.105B 94.10
Claritev (CTEV) United States $0.635B 0.00
Fulgent Genetics (FLGT) United States $0.535B 0.00
Standard BioTools (LAB) United States $0.528B 0.00
Veradigm (MDRX) United States $0.503B 0.00
Butterfly Network (BFLY) United States $0.453B 0.00
Talkspace (TALK) United States $0.420B 125.50
TruBridge (TBRG) United States $0.328B 728.00
Outset Medical (OM) United States $0.311B 0.00
Health Catalyst (HCAT) United States $0.273B 0.00
Nyxoah SA (NYXH) Belgium $0.255B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.218B 0.00
CapsoVision (CV) United States $0.210B 0.00
Zepp Health (ZEPP) Netherlands $0.182B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
American Well (AMWL) United States $0.129B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.122B 0.00
MDxHealth SA (MDXH) Belgium $0.117B 0.00
CareCloud (CCLD) United States $0.100B 3.82
ImmunoPrecise Antibodies (IPA) Canada $0.079B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.078B 0.00
111 (YI) China $0.060B 0.00
P3 Health Partners (PIII) United States $0.042B 0.00
HeartBeam (BEAT) United States $0.041B 0.00
Zhongchao (ZCMD) China $0.025B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Healthcare Triangle (HCTI) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00